Total Payments
$802.13
2023 Payments
$167.55
Companies
16
Transactions
25
Medicare Patients
201
Medicare Billing
$24,629
Payment Breakdown by Category
Food & Beverage$620.15 (77.3%)
Education$181.98 (22.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $620.15 | 23 | 77.3% |
| Education | $181.98 | 2 | 22.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $150.41 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $128.53 | 2 | $0 (2020) |
| Amgen Inc. | $112.56 | 3 | $0 (2022) |
| Astellas Pharma US Inc | $99.99 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $44.56 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $44.54 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $39.37 | 2 | $0 (2023) |
| EISAI INC. | $31.47 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $30.16 | 2 | $0 (2022) |
| Heron Therapeutics, Inc. | $24.37 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $167.55 | 8 | Merck Sharp & Dohme LLC ($44.56) |
| 2022 | $384.74 | 8 | E.R. Squibb & Sons, L.L.C. ($129.11) |
| 2020 | $110.00 | 1 | AstraZeneca Pharmaceuticals LP ($110.00) |
| 2019 | $19.13 | 1 | Agios Pharmaceuticals, Inc. ($19.13) |
| 2018 | $27.31 | 2 | Clovis Oncology, Inc. ($14.66) |
| 2017 | $93.40 | 5 | Amgen Inc. ($30.57) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Oncology | ||||||
| 12/05/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Oncology | ||||||
| 11/29/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), REBLOZYL, WELIREG | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: ONCOLOGY | ||||||
| 09/08/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/29/2023 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $21.30 | General |
| Category: Oncology | ||||||
| 07/10/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Oncology | ||||||
| 06/28/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $16.97 | General |
| 09/22/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Rare Disease | ||||||
| 08/26/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 08/17/2022 | Amgen Inc. | — | Education | In-kind items and services | $81.99 | General |
| 08/02/2022 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug), ONIVYDE | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Oncology/Endocrinology | ||||||
| 07/27/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Oncology | ||||||
| 07/27/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $4.11 | General |
| Category: Oncology | ||||||
| 06/07/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Rare Disease | ||||||
| 05/03/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $31.47 | General |
| Category: Oncology | ||||||
| 01/29/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $110.00 | General |
| 09/05/2019 | Agios Pharmaceuticals, Inc. | TIBSOVO (Drug), IDHIFA | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: ONCOLOGY | ||||||
| 04/09/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Oncology | ||||||
| 02/14/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: BioOncology | ||||||
| 12/18/2017 | Amgen Inc. | Neulasta (Biological), NEUPOGEN, Vectibix | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Oncology | ||||||
| 11/08/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug), DARZALEX, YONDELIS | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Oncology | ||||||
| 08/31/2017 | Amgen Inc. | Neulasta (Biological), NEUPOGEN, Vectibix | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Oncology | ||||||
| 04/05/2017 | Heron Therapeutics, Inc. | SUSTOL (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: CINV | ||||||
| 04/05/2017 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 115 | 123 | $57,927 | $15,327 |
| 2022 | 2 | 75 | 91 | $19,931 | $8,390 |
| 2021 | 1 | 11 | 11 | $2,123 | $912.34 |
Total Patients
201
Total Services
225
Medicare Billing
$24,629
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $22,752 | $6,110 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $21,555 | $5,557 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 25 | $9,200 | $2,487 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 17 | $4,420 | $1,173 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 51 | $12,869 | $5,464 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 40 | $7,062 | $2,926 | 41.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 11 | 11 | $2,123 | $912.34 | 43.0% |
About Dr. Siting Chen, MD
Dr. Siting Chen, MD is a Hematology & Oncology healthcare provider based in Vancouver, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689662587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Siting Chen, MD has received a total of $802.13 in payments from pharmaceutical and medical device companies, with $167.55 received in 2023. These payments were reported across 25 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($620.15).
As a Medicare-enrolled provider, Chen has provided services to 201 Medicare beneficiaries, totaling 225 services with total Medicare billing of $24,629. Data is available for 3 years (2021–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Vancouver, WA
- Active Since 10/13/2005
- Last Updated 05/28/2019
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1689662587
Products in Payments
- OPDIVO (Biological) $129.11
- KEYTRUDA (Biological) $44.56
- Lenvima (Drug) $31.47
- Neulasta (Biological) $30.57
- ULTOMIRIS (Biological) $30.16
- IMBRUVICA (Drug) $24.61
- SUSTOL (Drug) $24.37
- PYLARIFY (Drug) $24.36
- KISQALI (Drug) $22.40
- OPDUALAG (Drug) $21.30
- ZYTIGA (Drug) $19.93
- TIBSOVO (Drug) $19.13
- FASLODEX (Drug) $18.53
- Rubraca (Drug) $14.66
- FOTIVDA (Drug) $13.35
- TECENTRIQ (Biological) $12.65
- SOMATULINE DEPOT (Drug) $12.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Vancouver
Dr. Kathryn Kolibaba, M.d, M.D
Hematology & Oncology — Payments: $254,070
Hematology & Oncology $254,070
David Cosgrove, M.d, M.D
Hematology & Oncology — Payments: $24,551
Hematology & Oncology $24,551
Dr. David Smith, M.d, M.D
Hematology & Oncology — Payments: $19,096
Hematology & Oncology $19,096
Xing-Yue He, Md, MD
Hematology & Oncology — Payments: $18,869
Hematology & Oncology $18,869
Dr. Gary Cecchi, M.d, M.D
Hematology & Oncology — Payments: $16,561
Hematology & Oncology $16,561
Zizhen Feng, M.d., Phd, M.D., PHD
Hematology & Oncology — Payments: $3,006
Hematology & Oncology $3,006